Currency: AUD
Period
FY2023 Annual Report
--
-0.02
-11.38M
Strong Buy
Feb 1, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Antisense Therapeutics Ltd: Appendix 4E and Annual Report
Aug 25, 2023 04:08 ET
Antisense Therapeutics Ltd: Half Yearly Report and Accounts
Feb 22, 2023 00:24 ET
Antisense Therapeutics Ltd: Annual Report
Oct 18, 2022 18:10 ET
Antisense Therapeutics Ltd: Appendix 4E and Full Year Statutory Accounts
Aug 31, 2022 02:10 ET
Read more
Updated: Feb 1, 2024
Buy
Hold
Underperform
Sell
No Data